Cyclophosphamide - NDC Database
0781-3233 Oct 31, 2014
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
0781-3244 Oct 31, 2014
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
0781-3255 Oct 31, 2014
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Sandoz Inc.
10019-935 May 21, 2008
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-936 May 21, 2008
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-937 May 21, 2008
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-938 May 21, 2008
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-939 May 21, 2008
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-942 May 21, 2008
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-943 May 21, 2008
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-944 May 21, 2008
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-945 May 21, 2008
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 2 g/100ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-955 May 21, 2008
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 500 mg/25ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
10019-956 May 21, 2008
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Cyclophosphamide 1 g/50ml Intravenous; Oral Injection, Powder, for Solution by Baxter Healthcare Corporation
Note: The MedsChat® NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.